Common adverse effects of Rybelsus include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, abdominal pain, and constipation (particularly during dose titration) Reduced appetite : which may be therapeutic but can be problematic in some patients Potential pancreatitis : rare but serious
Moin ASM, Butler AE (2019) Alterations in beta cell identity in type 1 and type 2 diabetes
For signicant deciencies, injections might be administered more frequently at the start (e.g., weekly), and once levels stabilize, the frequency can be reduced (e.g., monthly)
When the patient take it, its effective
they have also recently been approved in other indications, such as cardiovascular disease prevention and sleep apnea
Systolic (SBP) and diastolic blood pressure (DBP) were also consistently reduced by incretin-based drugs, ranging from 3.1 and 0.57 mmHg with liraglutide 3.0 mg to 9.2 and 5.1 mmHg with retatrutide, respectively